Nutritionally variant streptococci - Revision history

Aidan at 19:28, 11 March 2022

2022-03-11T19:28:33Z

← Older revision		Revision as of 19:28, 11 March 2022
Line 14:		Line 14:
	== Management ==		== Management ==

	* Susceptibilities shown below are from ~~one~~ ~~small study~~[[CiteRef::kanamoto2018an]]		* Susceptibilities shown below are from several studies[[CiteRef::kanamoto2018an]][[CiteRef::patel2017an]][[CiteRef::mushtaq2016di]]

	{\| class="wikitable"		{\| class="wikitable"
Line 23:		Line 23:
	\|-		\|-
	\|Penicillin		\|Penicillin
	\|57%		\|14 to 57%
	\|82%		\|34 to 82%
	\|100%		\|80 to 100%
	\|-		\|-
	\|Ampicillin		\|Ampicillin
Line 43:		Line 43:
	\|-		\|-
	\|Ceftriaxone		\|Ceftriaxone
	\|100%		\|92 to 100%
	\|76%		\|22 to 76%
	\|100%		\|90 to 100%
	\|-		\|-
	\|Ceftazidime		\|Ceftazidime
Line 56:		Line 56:
	\|100%		\|100%
	\|100%		\|100%
			\|-
			\|Meropenem
			\|72 to 81%
			\|87 to 95%
			\|91%
	\|-		\|-
	\|Gentamicin		\|Gentamicin
Line 66:		Line 71:
	\|18%		\|18%
	\|17%		\|17%
			\|-
			\|Levofloxacin
			\|100%
			\|97 to 100%
			\|92%
	\|-		\|-
	\|Minocycline		\|Minocycline
Line 75:		Line 85:
	\|100%		\|100%
	\|100%		\|100%
	\|83%		\|83 to 100%
	\|-		\|-
	\|TMP-SMX		\|TMP-SMX

Aidan at 19:17, 11 March 2022

2022-03-11T19:17:34Z

← Older revision		Revision as of 19:17, 11 March 2022
Line 12:		Line 12:
	* [[Subacute bacterial endocarditis]] is the most well-known disease association		* [[Subacute bacterial endocarditis]] is the most well-known disease association

			== Management ==

			* Susceptibilities shown below are from one small study[[CiteRef::kanamoto2018an]]

			{\| class="wikitable"
			!Antibiotic
			![[Abiotrophia defectiva]]
			![[Granulicatella adiacens]]
			![[Granulicatella elegans]]
			\|-
			\|Penicillin
			\|57%
			\|82%
			\|100%
			\|-
			\|Ampicillin
			\|86%
			\|100%
			\|100%
			\|-
			\|Piperacillin
			\|0%
			\|53%
			\|100%
			\|-
			\|Cefazolin
			\|29%
			\|88%
			\|100%
			\|-
			\|Ceftriaxone
			\|100%
			\|76%
			\|100%
			\|-
			\|Ceftazidime
			\|0%
			\|0%
			\|50%
			\|-
			\|Imipenem
			\|100%
			\|100%
			\|100%
			\|-
			\|Gentamicin
			\|0%
			\|0%
			\|0%
			\|-
			\|Ciprofloxacin
			\|100%
			\|18%
			\|17%
			\|-
			\|Minocycline
			\|57%
			\|94%
			\|100%
			\|-
			\|Vancomycin
			\|100%
			\|100%
			\|83%
			\|-
			\|TMP-SMX
			\|14%
			\|0%
			\|17%
			\|}
	[[Category:Gram-positive cocci]]		[[Category:Gram-positive cocci]]

Aidan: Text replacement - "Clinical Presentation" to "Clinical Manifestations"

2020-07-19T12:14:52Z

Text replacement - "Clinical Presentation" to "Clinical Manifestations"

← Older revision		Revision as of 12:14, 19 July 2020
Line 9:		Line 9:
	* ''[[Granulicatella para-adiacens]]''		* ''[[Granulicatella para-adiacens]]''

	== Clinical ~~Presentation~~ ==		== Clinical Manifestations ==
	* [[Subacute bacterial endocarditis]] is the most well-known disease association		* [[Subacute bacterial endocarditis]] is the most well-known disease association

Aidan: Created page with "== Background == * Require pyridoxine (vitamin B6) supplementation to group * Also called pyridoxal-dependent or stalliting streptococci == Organisms == * ''Abiotrophia def..."

2020-03-06T15:44:46Z

Created page with "== Background == * Require pyridoxine (vitamin B6) supplementation to group * Also called pyridoxal-dependent or stalliting streptococci == Organisms == * ''Abiotrophia def..."

New page

== Background ==
* Require pyridoxine (vitamin B6) supplementation to group
* Also called pyridoxal-dependent or stalliting streptococci

== Organisms ==
* ''[[Abiotrophia defectiva]]''
* ''[[Granulicatella adiacens]]''
* ''[[Granulicatella elegans]]''
* ''[[Granulicatella para-adiacens]]''

== Clinical Presentation ==
* [[Subacute bacterial endocarditis]] is the most well-known disease association

[[Category:Gram-positive cocci]]